PRIYANKA PATEL: Open Payments
NPI 1346029550 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 55 payments from 14 companies in 2025. Trend: 2023 $293 · 2024 $1,394 · 2025 $1,613
Food & beverage: $1,528Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $326 |
| Madrigal Pharmaceuticals | 14 | $263 |
| ABBVIE INC. | 11 | $241 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $218 |
| Celltrion USA Inc. | 4 | $182 |
| Lilly USA, LLC | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Intercept Pharmaceuticals, Inc. | 1 | $54 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, SKYRIZI, OMVOH, ZYMFENTRA, RINVOQ, VEGZELMA.
Industry payments across FL — which companies pay providers there.
